Publications of Eoin Molloy

Journal Article (1)

2021
Journal Article
Molloy, E.; Mueller, K.; Beinhölzl, N.; Blöchl, M.; Piecha, F. A.; Pampel, A.; Steele, C.; Scharrer, U.; Zheleva, G.; Regenthal, R. et al.; Sehm, B.; Nikulin, V. V.; Möller, H. E.; Villringer, A.; Sacher, J.: Modulation of premotor cortex response to sequence motor learning during escitalopram intake. Journal of Cerebral Blood Flow and Metabolism 41 (6), pp. 1449 - 1462 (2021)

Meeting Abstract (1)

2017
Meeting Abstract
Beinhölzl, N.; Naor, N.; Okon-Singer, H.; Buchenau, A.; Scharrer, U.; Molloy, E.; Villringer, A.; Sacher, J.: A novel social perception task for testing thesocial interaction model in pharmaco-fMRIprotocols with selective serotonin reuptakeinhibitors. In European Neuropsychopharmacology, 27 (Suppl. 4), pp. S718 - S719. Elsevier, Amsterdam (2017)

Poster (4)

2019
Poster
Molloy, E.; Mueller, K.; Sehm, B.; Kanaan, A. S.; Pampel, A.; Steele, C.; Nikulin, V. V.; Bazin, P.-L.; Beinhölzl, N.; Zheleva, G. et al.; Piecha, F.; Ihle, K.; Blöchl, M.; Scharrer, U.; Regenthal, R.; Möller, H. E.; Villringer, A.; Sacher, J.: Serotonergic modulation of behavioural and neural responses during motor learning. 2019 OHBM Annual Meeting, Rome, Italy (2019)
Poster
Beinhölzl, N.; Molloy, E.; Richter, T.; Zheleva, G.; Piecha, F.; Scharrer, U.; Regenthal, R.; Villringer, A.; Okon-Singer, H.; Sacher, J.: No effect of escitalopram on cognition during an emotional distractor task: A randomised, placebo-controlled clinical study. 9th IMPRS NeuroCom Summer School, Leipzig, Germany (2019)
Poster
Zheleva, G.; Zsido, R.; Molloy, E.; Cesnaite, E.; Beinhölzl, N.; Scharrer, U.; Nikulin, V. V.; Regenthal, R.; Villringer, A.; Sacher, J.: The effects of subacute escitalopram administration on resting state EEG in a sample of healthy females. 9th IMPRS NeuroCom Summer School, Leipzig, Germany (2019)
2017
Poster
Beinhölzl, N.; Noar, N.; Okon-Singer, H.; Buchenau, A.; Scharrer, U.; Molloy, E.; Backhausen, L.; Villringer, A.; Sacher, J.: A novel social perception task for testing the social interaction model in pharmaco-fMRI protocols with selective serotonin reuptake inhibitors. 30th European College of Neuropsychopharmacology Congress, Paris, France (2017)
Go to Editor View